From the Guidelines
Hyperammonemia in a neonate indicates a potentially life-threatening condition that requires immediate medical attention.
Causes and Symptoms
- Hyperammonemia can be caused by inborn errors of metabolism, such as urea cycle disorders (UCDs) and organic acidaemias 1.
- Symptoms of hyperammonemia in neonates include lethargy, loss of appetite, vomiting, hypotonia, and hyperventilation, which can progress to seizures, coma, and death if left untreated 1.
- The clinical features of an acute hyperammonaemic episode depend on the age of the patient and the underlying cause of hyperammonaemia 1.
Diagnosis and Treatment
- Hyperammonemia is defined as >100 µmol/l (170 µg/dl) in neonates 1.
- Treatment of hyperammonemia in neonates may involve non-kidney replacement therapy (NKRT) and kidney replacement therapy (KRT), including peritoneal dialysis (PD), haemodialysis (HD), and continuous kidney replacement therapy (CKRT) 1.
- Hybrid therapy, such as CKRT with extracorporeal membrane oxygenation (ECMO) support, may be recommended in certain situations, such as haemodynamic instability or rapidly deteriorating neurological status 1.
Prognosis and Outcomes
- The prognosis for neonates with hyperammonemia has improved with current treatments, but prompt identification and treatment are crucial to prevent long-term neurological damage and improve survival 1.
- The duration of hyperammonaemic coma prior to the start of dialysis is a major determinant of survival, and patient outcomes are not influenced by the rate of ammonia clearance 1.
From the Research
Hyperammonemia in Neonates
Hyperammonemia in neonates indicates a serious condition that requires immediate medical attention. The key points to consider are:
- Hyperammonemia is defined as a plasma ammonia level above 100 µmol/L in neonates 2
- It can be caused by inherited metabolic diseases, as well as acquired disorders such as liver failure, portosystemic shunting, and infections with urea-metabolizing organisms 2
- Transient hyperammonemia of the newborn (THAN) is a special type of hyperammonemia that can be diagnosed only after excluding genetic and acquired causes of hyperammonemia 2, 3
- Hyperammonemia can lead to life-threatening neuropsychiatric symptoms, including seizures, coma, and cognitive impairment 2, 4
- The prognosis for THAN is generally good, but timely identification and treatment are essential to prevent long-term neurological damage 2, 3
Clinical Presentation
The clinical presentation of hyperammonemia in neonates may include:
- Respiratory distress syndrome
- Lethargy
- Hypotonia
- Seizures
- Coma
- Hyperammonemic coma in ill premature infants 5
Treatment and Management
Treatment and management of hyperammonemia in neonates may involve:
- Dialysis, which has been shown to be an effective treatment for hyperammonemia 3, 6
- Metabolite scavenger (MS) administration, which can help reduce ammonia levels 6
- Increasing the length of stay in the neonatal intensive care unit (NICU) to improve short-term survival 6
- Monitoring of peak ammonia levels, with further intervention administered when levels exceed 406.5 µmol/L 6